Iclusig
E1188112
UNEXPLORED
Iclusig is a cancer medication containing ponatinib, primarily used to treat certain types of leukemia such as chronic myeloid leukemia (CML) and Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL).
All labels observed (1)
| Label | Occurrences |
|---|---|
| Iclusig canonical | 1 |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.